LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
Goldman Sachs Initiates Coverage On LifeStance Health Gr with Neutral Rating, Announces Price Target of $9
LifeStance Health Group Inc (NASDAQ:LFST) Shows Strong Momentum on Minervini Trend Template and High Growth Fundamentals
Assessing LifeStance Health Group (LFST) Valuation After Recent Share Price Momentum
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
3 Reasons to Avoid LFST and 1 Stock to Buy Instead
5 Revealing Analyst Questions From LifeStance Health Group’s Q1 Earnings Call
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9
LifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?
LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?
Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
LifeStance Health Group (LFST) Stock Trades Down, Here Is Why
LFST Q1 Deep Dive: Technology and Clinician Productivity Drive Outperformance and Guidance Increase
LifeStance Health Group, Inc. 2026 Q1 - Results - Earnings Call Presentation
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $12
LifeStance Health Group Q1 Earnings Call Highlights
LifeStance (LFST) Hits 2-Year High as Q1 Profits Soar 1,900%
LifeStance Health Group Announces Pricing of Secondary Public Offering
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.